Recombinant Human Epidermal Growth Factor
Referencia orb2692604-1mg
embalaje : 1mg
Marca : Biorbyt
Description
Research Area
Stem Cell & Developmental Biology
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Expression System | E.coli |
|---|---|
| Biological Activity | ≥1×10^6 IU/mg |
| Endotoxins | < 1.0EU/mg |
| MW | 6.2KDa |
| Purity | > 98% by SDS-PAGE |
Storage & Handling
−| Storage | Storage Temp.: -20°C. Shelf Life: 36 months |
|---|---|
| Form/Appearance | lyophilized powder |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Recombinant epidermal growth factor, recombinant EGF, rEGF, EGF
−
Recombinant Human EGFR/ERBB1/HER1 Protein, C-His [orb2969725]
ELISA, SDS-PAGE, WB
>95% as determined by SDS-PAGE.
71.82 kDa
1 mg, 50 μg, 100 μgRecombinant Human EGFR Isoform vIII Protein [orb2994403]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 65.8 KDa. Observed: 90-120 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μgRecombinant Human EGFR Isoform vIII Protein [orb2994408]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.7 KDa. Observed: 61-75 Kda, reducing conditions
10 μg, 1 mg, 50 μg, 500 μgRecombinant Human EGFR Protein [orb2994530]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 69.6 KDa. Observed: 90-120 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg
Protocol Information
Protein Handling and Storage Guide
Protein Handling Guide